Market revenue in 2023 | USD 1,093.1 million |
Market revenue in 2030 | USD 1,796.6 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Localized autoimmune disease diagnostics |
Fastest growing segment | Systemic autoimmune disease diagnostics |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Systemic autoimmune disease diagnostics, Localized autoimmune disease diagnostics |
Key market players worldwide | Abbott Laboratories, BioMerieux SA, Trinity Biotech PLC ADR, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, BD, Beckman Coulter, Roche, Quest Diagnostics Inc, Siemens Healthineers AG ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to autoimmune disease diagnostics market will help companies and investors design strategic landscapes.
Localized autoimmune disease diagnostics was the largest segment with a revenue share of 64.86% in 2023. Horizon Databook has segmented the Asia Pacific autoimmune disease diagnostics market based on systemic autoimmune disease diagnostics, localized autoimmune disease diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific autoimmune disease diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific autoimmune disease diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account